Journals / Kocatepe Tıp Dergisi / 2014 / Cilt: 15 - Sayı: 2

Akut Koroner Sendromlu Hastalarda Eritrosit Dağılım Aralığının (RDW) Değerlendirilmesi

Pages
99–105
Publication Date
2014-08-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There was difference in all groups according to levels urea, creatinine, albumin, neutrophil count, RDW and troponin (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The RDW a recently described novel risk marker has been shown to be predictive of morbidity and mortality in variety of cardiovascular settings, and routinely reported as part of the complete blood count.
📊
Key Findings & Data:We thought that RDW can increase in patient with ACS and investigated the effect of RDW on the clinical and angiographic classification of ACS.
💡
Conclusion & Impact:There was difference in all groups according to levels urea, creatinine, albumin, neutrophil count, RDW and troponin (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Akut koroner sendrom · eritrosit dağılım aralığı · troponin

Abstract

Objective: The RDW a recently described novel risk marker has been shown to be predictive of morbidity and mortality in variety of cardiovascular settings, and routinely reported as part of the complete blood count. We thought that RDW can increase in patient with ACS and investigated the effect of RDW on the clinical and angiographic classification of ACS. Material and Methods: 236 patients with ACS, 46 patients with heart failure and 136 control patients were included to the study. ACS group divided into four subgroups clinically (stabil AP, unstabil AP, acute MI, non-cardiac AP) and angiographically divided into three subgroups (critical vascular occlusion, non-critical vascular occlusion, normal). The groups were compared according to laboratory parameters. Results: There was difference between heart failure group and the other groups according to levels of total cholesterol, triglyceride, calcium and WBC. There was difference in all groups according to levels urea, creatinine, albumin, neutrophil count, RDW and troponin (p

Özet

Amaç: Günümüzde yeni bir risk belirteci olarak tanımlanmış olan eritrosit dağılım aralığı (RDW), birçok kardiyovasküler hastalıkta mortalite ve morbiditenin prediktif bir değeri olarak gösterilmektedir ve tam kan sayımında rutin olarak çalışılmaktadır. Biz, RDW’nin, akut koroner sendromlu (ACS) hastalarda yükselebileceğini düşündük ve çalışmamızda ACS’nin klinik ve anjiyografik sınıflaması üzerine etkisini araştırdık. Gereç ve Yöntem: Çalışmaya ACS’li 236 hasta, kalp yetmezlikli 46 hasta ve 136 kontrol grubu hastası dahil edildi. ACS grubundaki hastalar klinik olarak 4 alt gruba (stabil AP, unstabil AP, akut MI ve non-kardiyak AP) ve anjiyografik olarak 3 alt gruba (kritik damar darlığı, non-kritik damar ve normal) ayrıldı. Gruplar ve grupların alt tipleri çalışılan laboratuvar parametreleri açısından karşılaştırıldı. Bulgular: Kalp yetmezliği grubuyla diğer gruplar arasında total kolesterol, trigliserid, kalsiyum ve lökosit (WBC) seviyelerine göre anlamlı bir fark mevcuttu (p

🔖

Cite This Article

ŞAHİN, H., POYRAZ, E. (2014). Akut Koroner Sendromlu Hastalarda Eritrosit Dağılım Aralığının (RDW) Değerlendirilmesi. Kocatepe Tıp Dergisi, Cilt: 15 - Sayı: 2, 99–105. https://ajindex.com/articles/686268

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Evans TC, Jehle D. The red blood cell distribution width. J Emerg Med 1991;9(1):71-4.
  2. Pierce CN, Larson DF. Inflammatory cytokine inhibition of erythropoiesis in patients implanted with a mechanical circulatory assist device. Perfusion 2005;20(2):83-90.
  3. Kato H, Ishida J, Imagawa S, et al. Enhanced erythropoiesis mediated by activation of the renin- angiotensin system via angiotensin II type 1a receptor. FASEB J 2005;19(14):2023-5.
  4. Biaggioni I, Robertson D, Krantz S, Jones M, Haile V. The anemia of primary autonomic failure and its reversal with recombinant erythropoietin. Ann Intern Med 1994;121(3):181-6.
  5. Ndrepepa G, Kastrati A, Braun S, et al. N-terminal probrain natriuretic peptide and C-reactive protein in stable coronary heart disease. Am J Med 2006;119(4):355.e1 Dai DF, Hwang JJ, Lin JL, et al. Joint effects of N- terminal pro-B-type-natriuretic peptide and C- reactive protein vs angiographic severity in predicting major adverse cardiovascular events and clinical restenosis after coronary angioplasty in patients with stable 2008;72(8):1316-23. artery coronary disease. Circ J Patel KV, Ferrucci L, Ershler WB, Longo DL, Guralnik JM. Red blood cell distribution width and the risk of death in middle-aged and older adults. Arch Intern Med 2009;169(5):515-23.
  6. Perlstein TS, Weuve J, Pfeffer MA, Beckman JA. Red blood cell distribution width and mortality risk in a community-based prospective cohort. Arch Intern Med 2009;169(6):588-94.
  7. Pascual-Figal DA, Bonaque JC, Redondo B, et al. Red blood cell distribution width predicts long-term outcome regardless of anaemia status in acute heart failure patients. Eur J Heart Fail 2009;11(9):840-6. Förhécz Z, Gombos T, Borgulya G, Pozsonyi Z, Prohászka Z, Jánoskuti L. Red cell distribution width in heart failure: prediction of clinical events and relationship erythropoiesis, inflammation, renal function, and nutritional state. Am Heart J 2009;158(4):659-66.
  8. Greer JP, Foerster J, Lukens JN, Rodgers GM, PAraksevas F, Glader BE (Editors). Wintrobe’s clinical hematology. In: Perkins SL. Examination pf blood and bone marrow. 11th Edition.
  9. Salt Lake City, Utah: Lippincott Wilkins & Williams; 2003:5-25.
  10. Fukuta H, Ohte N, Mukai S, et al. Elevated plasma levels of B-type natriuretic peptide but not C-reactive protein are associated with higher red cell distribution width in patients with coronary artery disease. Int Heart J 2009;50(3):301-12.
  11. Heymans S, Hirsch E, Anker SD, et al. Inflammation as a therapeutic target in heart fail